Skip to main content
. 2017 May 17;12(5):e0177793. doi: 10.1371/journal.pone.0177793

Fig 3. Overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombosis (mPVTT) vs. those without mPVTT (1-year OS, 18.7% vs. 56.1%).

Fig 3